• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C1QTNF6 受 miR-184 靶向调控,调节肺腺癌细胞的增殖、迁移和侵袭。

C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.

机构信息

Department of Cardio-Thoracic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Renming East Road, Wucheng District, Jinhua, 321000, Zhejiang, China.

出版信息

Mol Biotechnol. 2022 Nov;64(11):1279-1287. doi: 10.1007/s12033-022-00495-z. Epub 2022 May 17.

DOI:10.1007/s12033-022-00495-z
PMID:35578071
Abstract

OBJECTIVE

To seek out the mechanism by which C1QTNF6 mediates lung adenocarcinoma (LUAD).

METHODS

Differentially expressed mRNAs and miRNAs in LUAD were analyzed using bioinformatics. In LUAD cells, C1QTNF6 mRNA and miR-184 expression were evaluated with qRT-PCR, and C1QTNF6 protein level was assessed by western blot. Cellular behaviors were assessed by colony formation, CCK-8, Transwell, and wound healing methods. The binding ability of miR-184 to C1QTNF6 was observed by dual-luciferase assay.

RESULTS

High expression of C1QTNF6 in LUAD stimulated cancer cellular behaviors. MiR-184 was lowly expressed in LUAD and downregulated C1QTNF6 expression. MiR-184 restrained LUAD cell processes by targeting C1QTNF6.

CONCLUSION

MiR-184 repressed LUAD cell processes via mediating C1QTNF6. MiR-184 and C1QTNF6 are expected to be indicators for LUAD treatment.

摘要

目的

探索 C1QTNF6 介导肺腺癌(LUAD)的机制。

方法

采用生物信息学方法分析 LUAD 中差异表达的 mRNA 和 miRNA。用 qRT-PCR 检测 LUAD 细胞中 C1QTNF6 mRNA 和 miR-184 的表达,用 Western blot 检测 C1QTNF6 蛋白水平。用集落形成、CCK-8、Transwell 和划痕愈合方法评估细胞行为。通过双荧光素酶报告基因实验观察 miR-184 与 C1QTNF6 的结合能力。

结果

在 LUAD 中 C1QTNF6 的高表达刺激了癌症细胞行为。miR-184 在 LUAD 中低表达,下调 C1QTNF6 的表达。miR-184 通过靶向 C1QTNF6 抑制 LUAD 细胞进程。

结论

miR-184 通过介导 C1QTNF6 抑制 LUAD 细胞进程。miR-184 和 C1QTNF6 有望成为 LUAD 治疗的指标。

相似文献

1
C1QTNF6 Targeted by MiR-184 Regulates the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.C1QTNF6 受 miR-184 靶向调控,调节肺腺癌细胞的增殖、迁移和侵袭。
Mol Biotechnol. 2022 Nov;64(11):1279-1287. doi: 10.1007/s12033-022-00495-z. Epub 2022 May 17.
2
miR-133b inhibits cell proliferation, migration, and invasion of lung adenocarcinoma by targeting CDCA8.miR-133b 通过靶向 CDCA8 抑制肺腺癌细胞的增殖、迁移和侵袭。
Pathol Res Pract. 2021 Jul;223:153459. doi: 10.1016/j.prp.2021.153459. Epub 2021 Apr 28.
3
miR-139-5p Inhibits Lung Adenocarcinoma Cell Proliferation, Migration, and Invasion by Targeting MAD2L1.miR-139-5p 通过靶向 MAD2L1 抑制肺腺癌细胞的增殖、迁移和侵袭。
Comput Math Methods Med. 2020 Nov 4;2020:2953598. doi: 10.1155/2020/2953598. eCollection 2020.
4
miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2.miR-30a-5p 通过靶向 ECT2 调节肺腺癌细胞的活力、迁移和侵袭。
Comput Math Methods Med. 2021 Jul 7;2021:6241469. doi: 10.1155/2021/6241469. eCollection 2021.
5
CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.环状PRKCI通过靶向miR-219a-5p调控的CAMK1D来调节肺腺癌细胞的增殖、迁移和周期。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1899-1909. doi: 10.26355/eurrev_202102_25085.
6
miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.miR-21-5p 通过靶向 WWC2 促进肺腺癌细胞的增殖、迁移和侵袭。
Cancer Biomark. 2020;28(4):549-559. doi: 10.3233/CBM-201489.
7
C1QTNF6 regulated by miR-29a-3p promotes proliferation and migration in stage I lung adenocarcinoma.miR-29a-3p 调控 C1QTNF6 促进Ⅰ期肺腺癌的增殖和迁移。
BMC Pulm Med. 2022 Jul 25;22(1):285. doi: 10.1186/s12890-022-02055-2.
8
miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.miR-186-5p 通过靶向 PTEN 促进肺腺癌细胞的生长、迁移和侵袭。
Exp Mol Pathol. 2019 Jun;108:105-113. doi: 10.1016/j.yexmp.2019.04.007. Epub 2019 Apr 11.
9
C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients.C1QTNF6 作为一种新型生物标志物,调节 A549 细胞的细胞行为,并加重肺腺癌患者的预后。
In Vitro Cell Dev Biol Anim. 2019 Sep;55(8):614-621. doi: 10.1007/s11626-019-00377-w. Epub 2019 Jul 10.
10
MiR-29c-3p/C1QTNF6 Restrains the Angiogenesis and Cell Proliferation, Migration and Invasion in Head and Neck Squamous Cell Carcinoma.miR-29c-3p/C1QTNF6 抑制头颈部鳞状细胞癌的血管生成和细胞增殖、迁移及侵袭。
Mol Biotechnol. 2023 Jun;65(6):913-921. doi: 10.1007/s12033-022-00591-0. Epub 2022 Nov 8.

引用本文的文献

1
Comprehensive characterization of pathogenic missense CTRP6 variants and their association with cancer.致病性错义CTRP6变异体的综合特征及其与癌症的关联
BMC Cancer. 2025 Feb 20;25(1):304. doi: 10.1186/s12885-025-13685-0.
2
Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses.基于 bulk、单细胞 RNA 测序和孟德尔随机化分析的肺腺癌代谢全景预测预后和免疫治疗疗效。
Aging (Albany NY). 2024 May 20;16(10):8772-8809. doi: 10.18632/aging.205838.
3
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review.
不同类型肺癌中微小RNA高效性的最新进展:综述
Cancer Cell Int. 2023 Nov 20;23(1):284. doi: 10.1186/s12935-023-03133-z.